Larvol Delta - atai-Life-Sciences-Reports-Second-Quarter-2023-Financial-Results-and-Operational-Highlights-and-Announces-Clinical-Data-from-the-Phase-1-Study-of-DMX1002-Ibogaine

RL-007 - atai Life Sci

N,N-dimethyltryptamine (VLS-01) - atai Life Sci

ibogaine (DMX-1002) - atai Life Sci

EMP-01 - atai Life Sci

https://www.globenewswire.com/news-release/2023/08/10/2722468/0/en/atai-Life-Sciences-Reports-Second-Quarter-2023-Financial-Results-and-Operational-Highlights-and-Announces-Clinical-Data-from-the-Phase-1-Study-of-DMX-1002-Ibogaine.html

Aug 10, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next